A Randomized, Parallel, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of 3 Oral Doses of ERB-041 in Subjects With Rheumatoid Arthritis on a Background of Methotrexate Therapy

INTERVENTION: Product Name: ERB‐041 Product Code: ERB‐041 Pharmaceutical Form: Capsule, hard CAS Number: 524684‐52‐4 Current Sponsor code: ERB‐041 Other descriptive name: NA Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 5‐ Product Name: ERB‐041 Product Code: ERB‐041 Pharmaceutical Form: Capsule, hard CAS Number: 524684‐52‐4 Current Sponsor code: ERB‐041 Other descriptive name: NA Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 25‐ Product Name: ERB‐041 Product Code: ERB‐041 Pharmaceutical Form: Capsule, hard CAS Number: 524684‐52‐4 Current Sponsor code: ERB‐041 Other descriptive name: NA Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 75‐ CONDITION: Rheumatoid arthritis ; MedDRA version: 6.1 Level: PT Classification code 10039073 PRIMARY OUTCOME: Main Objective: Primary end point(s): Secondary Objective: INCLUSION CRITERIA: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18‐64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range